Livento Group Posts Q2 Loss, Cash Dwindles to $22K, and Adds Toxic Convertible Debt
LIVG sits 57% above its 52-week low of $0.001 on elevated volume (1.9× avg).
Summary
Livento Group's Q2 2026 filing shows a net loss, near-zero cash, and new convertible debt with deeply discounted conversion terms that threaten massive dilution.
Key Events · Earnings and Guidance · LIVG
-
Q2 Net Loss
Net loss of $63,624 for Q2 2026, compared to net income of $147,331 in Q2 2025. Six-month loss of $442,793.
-
Cash Nearly Exhausted
Cash balance of $22,128 as of June 30, 2026, down from $5,628 at year-end 2025, insufficient to fund operations.
-
Toxic Convertible Debt
Six new promissory notes totaling $457,566.66 with conversion prices at 65% of the lowest trading price of three days, creating severe dilution risk.
-
Massive Share Issuance
Common shares outstanding increased from 221,450 at December 31, 2025 to 133,702,856 at June 30, 2026, a 60,000% increase.
Analysis · LIVG · Technology
The Q2 2026 10-Q from Livento Group paints a deteriorating financial picture: a net loss of $63,624 for the quarter, a cash balance of just $22,128, and six new convertible notes with conversion prices set at 65% of the lowest trading price — a structure that heavily dilutes existing shareholders. Common shares outstanding ballooned from 221,450 to 133.7 million in six months, indicating massive share issuance. With revenue declining and cash nearly exhausted, the company is relying on toxic financing to stay afloat, which poses severe downside risk for current investors.
At the time of this filing, LIVG was trading at $0.00 on OTC in the Technology sector, with a market capitalization of approximately $149.6K. The 52-week trading range was $0.00 to $3,080,000.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.